Clinical trials – Page 4

News
Tufts’ $2.6bn drug development figure questioned

2014-12-05T00:00:00Z

Details sought about how university determined cost of bringing a drug to market jumped 145% since 2003
News
Ebola vaccine passes first safety hurdle

2014-12-03T00:00:00Z

Researchers hope to begin larger trials of its effectiveness in west Africa soon
News
US agency fast-tracks Ebola vaccine development

2014-10-23T00:00:00Z

Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’
Business
EMA finalises trial transparency rules

2014-10-08T00:00:00Z

Researcher access reinstated, but company redaction rights may cause issues
Feature
Transparency measures forced on pharma

2014-09-30T00:00:00Z

Previous misdemeanours are compelling the pharmaceutical industry to be more open with financial information and clinical data, writes Nuala Moran
News
NIH wants scientists to consider sex in research

2014-09-26T00:00:00Z

Preclinical and clinical research is overreliant on male test subjects which can cloud future work in humans
Business
Review says cheaper drug is safe for eye disease

2014-09-24T00:00:00Z

Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
Business
Servier to appear in adverts over lack of transparency

2014-09-05T00:00:00Z

Adverts in the medical press will name French pharma firm for failing to comply with disclosure rules
News
Doctors turn to experimental Ebola treatments

2014-08-20T00:00:00Z

Drugs and vaccines untested in humans are being trialled on Ebola patients
Business
EMA wrangles restrain trial data progress

2014-07-03T00:00:00Z

Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
Business
Biotech bounced back in 2013, says report

2014-06-24T00:00:00Z

R&D investment increasing, but industry needs to use its cash more wisely
Business
UK to fast-track access to critical medicines

2014-03-17T00:00:00Z

Patients could receive medicines before formal approval in exchange for monitoring data
Business
Roche disputes unethical East German trial claims

2014-02-26T00:00:00Z

Internal investigation concludes that 1980s trials were legally run and patients gave proper consent
Business
J&J puts trial data in independent hands

2014-02-04T00:00:00Z

Yale University’s YODA seeks to help pharma avoid the dark side by acting as gatekeeper for patient records
Business
Novartis in the spotlight in mis-selling investigations

2014-01-09T00:00:00Z

Crackdown on pharma marketing continues with US and Japanese cases
News
Rough patch for India’s clinical trial industry

2013-11-12T00:00:00Z

Bad publicity has added to the woes of an industry worried by regulatory uncertainty
News
Supreme court ruling brings clinical trials to a halt in India

2013-10-15T00:00:00Z

Pressure from campaign group precipitates action that puts 162 drug trials on ice
Business
GSK to apply for malaria vaccine approval

2013-10-09T00:00:00Z

Infection protection drops over time, but the firm will go ahead with regulatory submission
Business
Japan confirms Novartis clinical trial data fabrication

2013-10-01T00:00:00Z

Investigation into blood pressure blockbuster continues
Business
GSK criticised for trial data secrecy

2013-09-17T00:00:00Z

Italian research institute abandons collaboration over data access